Intravenous low dose esmolol in treating patients with supraventricular tachyarrythmias
Sheng-Chi Wang
Abstract
Sheng-Chi Wang
Abstract
AIM: To observe the efficacy of intravenous low dose esmolol in treating patients with supraventricular tachyarrythmias(SVT). METHODS: A total of thirty patients with STV:including ten patients with sinus tachycardia, seven patients with paroxysmal supraventricular tachycardia, nine patients with atria fibrillation and four patients with flutter [M 17,F 13;age(48± s 15 a) received iv bolus esmolol 3-5 mg, and followed by an intravenous drip 1-3 mg·min -1. The ventricular heart rate and blood pressure, ECG were recorded before and after treatment 1 h of treatment. RESULTS: The heart rate after treatment 1 h was (99±31) beat·min -1 obvious lower than (147±16)beat·min -1 before treatment (P0.01). The total effective rate was 83 %. It was effective for the treatment of the above four types of SVT. Hypotension occurred in only one patient, and resolved within 20 min after discontinuation of esmolol infusion. CONCLUSION: The result of the study indicates that intrarenous low dose esmolol is effective for the treatment of SVT.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
AIM: To observe the efficacy of intravenous low dose esmolol in treating patients with supraventricular tachyarrythmias(SVT). METHODS: A total of thirty patients with STV:including ten patients with sinus tachycardia, seven patients with paroxysmal supraventricular tachycardia, nine patients with atria fibrillation and four patients with flutter [M 17,F 13;age(48± s 15 a) received iv bolus esmolol 3-5 mg, and followed by an intravenous drip 1-3 mg·min -1. The ventricular heart rate and blood pressure, ECG were recorded before and after treatment 1 h of treatment. RESULTS: The heart rate after treatment 1 h was (99±31) beat·min -1 obvious lower than (147±16)beat·min -1 before treatment (P0.01). The total effective rate was 83 %. It was effective for the treatment of the above four types of SVT. Hypotension occurred in only one patient, and resolved within 20 min after discontinuation of esmolol infusion. CONCLUSION: The result of the study indicates that intrarenous low dose esmolol is effective for the treatment of SVT.
Key concepts: Esmolol, Medicine, Supraventricular tachycardia, Heart rate, Anesthesia, Discontinuation, Atrial flutter, Bolus (digestion)